Megola Completes Successful Pilot Scale-Up Field Testing of its Patent-Pending Odor Control (SAPs) for Baby Diapers, Adult Incontinence and Feminine Hygiene Products

Several hundred prototypes of the adult incontinence diapers were produced by a diaper manufacturer in Foshan City, Guangdong China, who sells 2,450,000,000 pcs of diapers every year and provided to a group of incontinent human volunteers in the USA.

Megola, Inc. (OTCMKTS:MGON) 

BONITA SPRINGS, FL, UNITED STATES, April 3, 2023 — (OTC-PINK MGON) Megola, Inc. (“MGON”, “Company”) a Consortium Group of Health Technologies and Eco-Friendly Product Lines announced the successful completion of its Pilot Scale-up Field Testing with its patent-pending Odor Control (SAPs) for Baby Diapers, Adult Incontinence and Feminine Hygiene Products. The odor control personal hygiene products were provided to a group of incontinent human volunteers in the USA. 

Superabsorbent Polymer granules (SAP) are used annually in diapers and pads of all types, in a global industry with an annual turnover of more than $100 billion

“It’s been a long time coming but controlling embarrassing odors from incontinence garments and feminine hygiene products is about to become a reality at last. We have perfected a simple method of coating the superabsorbent polymer granules (SAP) that stops odor formation in its tracks,” said Dr. Jeff Williams, Megola Advisory board and Chief Science Officer of MedeSol Global.

The successful pilot project involved several hundred prototypes of the adult incontinence diapers that were produced and provided to a group of incontinent human volunteers in the USA. The effectiveness of the odor control was quickly recognized by both them and their caregivers when these were worn instead of their regular hygiene products. Prolonged wear caused no irritation of sensitive areas of skin. Skin irritation testing conducted by an independent contractor according to an FDA approved protocol is underway, with results due shortly. As an added benefit, discarded, used devices no longer smell in the disposal chain.

Extensive laboratory testing of the patent-pending coated SAP granules Megola acquired from Medesol Global has been completed by scientists at two major universities. Using analytical chemistry and microbiology they demonstrated that malodorant compounds associated with diaper odor could be directly modified by the granules to form non-odorous reaction products, and that both the microbes and the enzymes they use to create malodors are also rapidly inactivated. The results will be submitted for publication in a peer reviewed scientific journal.   


Megola Signs Exclusive Global Supply and Distribution Agreement with Leader in Mobile Device Protection Coatings. Global Distribution Deal: Revenues of $10 million for Revolutionary Mobile Phone Protection Technology

Stock information here:

John MacLeod
Megola Inc
+1 888-587-1698


Forward-Looking Statements
The statements contained in this release that are not historical facts are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “could,” “should,” “expect,” “plan,” “project,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “pursuant,” “target,” “continue,” and similar expressions are intended to identify such forward-looking statements. The statements in this press release that are not historical statements, including statements regarding MGON’s plans, objectives, future opportunities for MGON’s services, future financial performance and operating results and any other statements regarding MGON’s future expectations, beliefs, plans, objectives, financial conditions, assumptions or future events or performance that are not historical facts, are forward-looking statements within the meaning of the federal securities laws. These statements are not guarantees of future performance and are subject to numerous risks, uncertainties, and assumptions, many of which are beyond MGON’s control, and which could cause actual results to differ materially from the results expressed or implied by the statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict, and include, without limitation, results of litigation, settlements and investigations; actions by third parties, including governmental agencies; volatility in customer spending; global economic conditions; ability to hire and retain personnel; loss of, or reduction in business, with key customers; difficulty with growth and integration of acquisitions; product liability; cybersecurity risk; and, anti-takeover measures in our charter documents. Any forward-looking statement is made only as of the date of which such statement is made. Except as otherwise required by applicable law, we undertake no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.